杂志简称：j oncol pharm pract
中文译名：《肿瘤药学实践杂志》
收录属性：scie（2024版）, 目次收录（维普）, 目次收录（知网）,英文期刊,
自引率：15.40%
投稿方向：医学、oncology肿瘤学、pharmacology & pharmacy药学
SCI/E期刊基本信息
出版周期：周刊 地区：英国
中科院分区：4区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN 1078-1552;EISSN 1477-092X
杂志语言：英语
出版国家：英国
杂志官网 联系方式
出版地址：1 OLIVERS YARD,55 CITY ROAD,LONDON,ENGLAND,EC1Y 1SP
杂志邮箱：
投稿网址：https://mc.manuscriptcentral.com/jopp
杂志官方网址：https://journals.sagepub.com/home/opp
出版商网址：http://www.sagepub.co.uk
杂志投稿要求
投稿须知【杂志社官方网站信息】
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
Manuscript Submission Guidelines:
Manuscript Submission Guidelines: Journal of Oncology Pharmacy Practice
This Journal is a member of the Committee on Publication Ethics.
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the Journal’s submission site http://mc.manuscriptcentral.com/jopp to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.
Only manuscripts of sufficient quality that meet the aims and scope of Journal of Oncology Pharmacy Practice will be reviewed.
There are no fees payable to submit or publish in this journal.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
1.1 Aims & Scope
Before submitting your manuscript to Journal of Oncology Pharmacy Practice, please ensure you have read the Aims & Scope.
The Journal of Oncology Pharmacy Practice (JOPP) is a peer-reviewed scholarly journal dedicated to educating health professionals about providing pharmaceutical care to patients with cancer and is the official publication of the International Society for Oncology Pharmacy Practitioners (ISOPP).
JOPP publishes cancer drug therapy and cancer disease management review articles, research papers, pertinent case reports, editorials, and consensus guidelines that drive clinical practice.
As the official publication of the International Society for Oncology Pharmacy Practitioners (ISOPP), JOPP contains articles about practical issues relating to oncology pharmacy including papers about safe handling of cytotoxic agents.
1.2 Article Types
Manuscripts are considered for publication with the understanding that they have not been published previously and are not under consideration by another publication. However, the journal will consider manuscripts previously presented as limited posters and abstracts during conferences or in supplements.
The journal publishes review articles, original research papers, practice guidelines, practice issues, case reports, letters to the editor, and editorials/commentaries.
Submissions of any article type do not have a strict restriction on word count, tables/figures or references. Submitting authors are encouraged to use what is necessary and appropriate for their manuscript, but note that the peer review process may suggest or request a reduction in any of these aspects.
Review Articles. Comprehensive and critical reviews of drug use in cancer patient care. For medication review articles please include introduction, pharmacology, pharmacokinetics/ pharmacodynamics, therapeutic use, clinical use controversies, product description (cost, special preparation and/or administrative considerations), and perspectives on use (summary paragraph including how this drug fits into current practice). For disease and supportive care management reviews include introduction, epidemiology, etiology, pathophysiology, patient presentation, common staging systems used (for malignancy treatment reviews), treatment (include surgery, radiation, but focus on drug therapy aspects), and summary. It is highly desirable to include a flow-diagram treatment algorithm to summarize disease management.
Original Research Articles. Articles should include a clear statement of purpose; a brief historical review; and a description of the methods, procedures, subjects used, statistical analysis, results, discussion, and conclusions (with clinical implications). For research involving human subjects, a statement must be included to assure that the principles set forth in the the Declaration of Helsinki 1975, revised Hong Kong 1989, were followed or that approval from a local or regional committee on human investigation was obtained. A statement must also be included attesting that informed consent was obtained from each subject or the subject's guardian.
Practice Guidelines. Institutional policies on medication use with outcome indicators.
Practice Issues. Reports of innovative services, policies, or outcome measure tools.
Case Series/Reports. Include an introduction justifying the case report, the case description, and discussion.
Letters to the Editor. Brief comments on articles published in the Journal or other information of interest to our readers.
Editorials/ Commentaries. Expression of opinions about controversial therapeutic areas or comments about practice-related issues are encouraged.
1.2.1 Abstract guidelines
Please ensure you include the following criteria in your abstract:
Research Article. Introduction (description of rationale for study), Methods (brief description of methods or study design), Results (summary of significant results), and Conclusions (succinct statement of data interpretation).
1.2 Article Types
Manuscripts are considered for publication with the understanding that they have not been published previously and are not under consideration by another publication. However, the journal will consider manuscripts previously presented as limited posters and abstracts during conferences or in supplements.
The journal publishes review articles, original research papers, practice guidelines, practice issues, case reports, letters to the editor, and editorials/commentaries.
Submissions of any article type do not have a strict restriction on word count, tables/figures or references. Submitting authors are encouraged to use what is necessary and appropriate for their manuscript, but note that the peer review process may suggest or request a reduction in any of these aspects.
Review Articles. Comprehensive and critical reviews of drug use in cancer patient care. For medication review articles please include introduction, pharmacology, pharmacokinetics/ pharmacodynamics, therapeutic use, clinical use controversies, product description (cost, special preparation and/or administrative considerations), and perspectives on use (summary paragraph including how this drug fits into current practice). For disease and supportive care management reviews include introduction, epidemiology, etiology, pathophysiology, patient presentation, common staging systems used (for malignancy treatment reviews), treatment (include surgery, radiation, but focus on drug therapy aspects), and summary. It is highly desirable to include a flow-diagram treatment algorithm to summarize disease management.
Original Research Articles. Articles should include a clear statement of purpose; a brief historical review; and a description of the methods, procedures, subjects used, statistical analysis, results, discussion, and conclusions (with clinical implications). For research involving human subjects, a statement must be included to assure that the principles set forth in the the Declaration of Helsinki 1975, revised Hong Kong 1989, were followed or that approval from a local or regional committee on human investigation was obtained. A statement must also be included attesting that informed consent was obtained from each subject or the subject's guardian.
……